Kimberly-Clark Exchange Offers Draw 90% of Kenvue Notes
AiX — Free Expert Advisor
Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.
Kimberly-Clark Corporation said on November 3, 2026 that its offers to exchange any and all outstanding Kenvue notes for up to $7,000,000,000 aggregate principal amount of new Kimberly-Clark notes and cash expired at 5:00 p.m. New York City time on November 2, 2026. Tender rates ran from 73.93% of the 5.050% senior notes due 2028 to 98.54% of the 5.050% senior notes due 2053, per the company's final results. Kimberly-Clark expects settlement on November 4, 2026.
Context — Why Kimberly-Clark Is Swapping Kenvue Debt Now
The exchange offers and related consent solicitations were made by Kimberly-Clark on behalf of Kenvue to amend the indenture governing the Kenvue notes, according to the company. Kimberly-Clark launched the offers under a confidential offering memorandum dated September 28, 2026, as amended.
The company reported that by 5:00 p.m. New York City time on October 9, 2026, the early participation date, it had received requisite consents to adopt the amendments, and a supplemental indenture containing those amendments was executed. The amendments become operative only when the exchange offers settle, which the company expects on November 4, 2026.
That sequencing matters. Consents are locked in, but the indenture changes do not bite until the new notes are delivered. If settlement slipped, the amendments would sit dormant. Kimberly-Clark did not disclose a contingency plan for that scenario.
Kimberly-Clark describes itself in the report as the parent of brands including Huggies, Listerine, Cottonelle, Neutrogena, Depend, Tylenol, Kleenex, Johnson's Baby, Kotex and Scott, serving consumers in more than 175 countries. It also states in the report that it has paid a dividend for 92 consecutive years and raised it in each of the past 54 years. Those claims are the company's own.
The macro backdrop is not given in the report. No benchmark Treasury yield, credit spread or index level appears in the disclosure, so the relative pricing of the new notes against the curve cannot be established from this document alone.
Data — What the Tender Numbers Show
Tender participation varied sharply by maturity, with the longest-dated series drawing the highest acceptance. The 2053 notes saw 98.54% tendered, while the 2028 notes drew the lowest rate at 73.93%.
| Kenvue series | Outstanding | Tendered | % tendered |
|---|---|---|---|
| 5.050% due 2028 | $1,000,000,000 | $739,347,000 | 73.93% |
| 5.000% due 2030 | $1,000,000,000 | $846,989,000 | 84.70% |
| 4.850% due 2032 | $750,000,000 | $702,706,000 | 93.69% |
| 4.900% due 2033 | $1,250,000,000 | $1,152,617,000 | 92.21% |
| 5.100% due 2043 | $750,000,000 | $728,377,000 | 97.12% |
| 5.050% due 2053 | $1,500,000,000 | $1,478,073,000 | 98.54% |
| 5.200% due 2063 | $750,000,000 | $727,930,000 | 97.06% |
Total outstanding across the seven series is $7,000,000,000, matching the cap Kimberly-Clark set for the new notes. Total tendered comes to roughly $6,376,039,000, leaving about $623,961,000 of Kenvue notes outstanding after settlement.
Consideration terms are identical across series. Holders who tendered at or before the early participation date were eligible for $970 in principal amount of Kimberly-Clark notes, a $30 premium in new notes and $1.00 in cash per $1,000 of Kenvue notes, per the company. Holders tendering after that date but by expiration were eligible for the $970 plus the $30 premium, without the cash payment.
Kimberly-Clark said the new notes will carry the same interest rate, interest payment dates, maturity date and optional redemption prices as the corresponding Kenvue series. The notes will be issued in minimum denominations of $2,000 and integral multiples of $1,000 above that, and the company will reject any tender that would produce less than $2,000 principal of any series.
Analysis — Who Is Exposed and What Changes
The structural shift is issuer substitution rather than new borrowing. Kimberly-Clark said the new notes will be its general, unsecured senior obligations, ranking equally with its existing and future unsecured senior debt and effectively subordinated to its secured debt to the extent of the collateral backing it. That ranking language is the company's characterization.
For holders, the credit behind the paper changes from Kenvue to Kimberly-Clark, while coupon, maturity and call features stay the same. The $1.00 cash payment applied only to early tenders, so late participants received the same principal consideration without the cash component.
Accrued interest mechanics are worth flagging. The company said no accrued and unpaid interest is payable on acceptance of Kenvue notes, but the first interest payment on the new Kimberly-Clark notes will include accrued interest from the tendered Kenvue notes, so a tendering holder receives the same interest payment it would have received without tendering. Kenvue remains responsible for interest accruing and payable before settlement, and for interest on any Kenvue notes still outstanding afterward.
The counter-argument is concentration. Because the 2053 and 2043 series tendered above 97%, remaining Kenvue float in those maturities is thin. Holders who did not participate hold smaller, less liquid positions, and the roughly $624m left outstanding is spread unevenly across the seven series.
Eligibility was restricted. The offers were made only to qualified institutional buyers under Rule 144A, to non-U.S. persons under Regulation S, and to specified non-retail categories in the EEA, UK and Canada. The new notes are unregistered, and the company said no regulatory authority has approved them or passed on the offering memorandum's adequacy.
Outlook — What to Watch Next
The settlement date of November 4, 2026 is the immediate checkpoint. Kimberly-Clark said the amendments to the Kenvue indenture become operative only on settlement, so that is the moment the new indenture terms take effect.
After settlement, the remaining Kenvue notes — roughly $623,961,000 across the seven series by the company's figures — stay outstanding under the amended indenture. Trading liquidity in those residual lines, particularly the 2053 and 2043 series with sub-3% free float, is the second thing to track.
The report gives no Treasury yield, credit spread, rating action or index level to anchor valuation, so no price threshold can be set from this disclosure. Kimberly-Clark also did not state whether it will register the new notes later or leave them in private form. Any rating agency action on the new Kimberly-Clark notes is likewise absent from the report.
Frequently Asked Questions
What does the Kimberly-Clark and Kenvue note exchange mean for retail investors?
Retail investors could not participate. The company said the offers were limited to qualified institutional buyers under Rule 144A, non-U.S. persons under Regulation S, and specified non-retail categories in the EEA, UK and Canada. The new Kimberly-Clark notes are unregistered and were not offered publicly. Retail exposure to the transaction, if any, comes indirectly through funds holding Kenvue or Kimberly-Clark debt.
What happens to Kenvue notes that were not tendered?
They remain outstanding after the November 4, 2026 settlement, governed by the amended Kenvue indenture. Based on the company's figures, about $623,961,000 across the seven series was not tendered. Kenvue remains responsible for interest on those notes. Holders keep the original coupon and maturity but now sit in smaller, potentially less liquid positions, especially in the 2043 and 2053 series.
Why did the longer-dated Kenvue notes tender at higher rates?
The report does not explain the pattern. The 2053 notes tendered at 98.54% and the 2043 notes at 97.12%, versus 73.93% for the 2028 notes. One observable fact is that the consideration was identical across series — $970 principal plus a $30 premium, and $1.00 cash for early tenders. Beyond that, the disclosure offers no stated rationale for the maturity split.
Bottom Line
Kimberly-Clark locked in roughly $6.38bn of Kenvue note tenders and settles the swap on November 4, 2026.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Trade XAUUSD on autopilot — free Expert Advisor
AiX is our free MetaTrader 5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.
PartnerPosition yourself for the macro moves discussed above
Start TradingSponsored
Ready to trade the markets?
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.